Anti-CD20 monoclonal antibody therapy for non-Hodgkin's lymphoma

被引：0
|
作者：
White, CA
Weaver, R
Royston, I
机构：
[1] Idec Pharmaceut Corp, San Diego, CA 92121 USA
[2] Sidney Kimmel Canc Ctr, San Diego, CA USA
来源：
MINERVA BIOTECNOLOGICA | 1998年 / 10卷 / 03期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：108 / 116
页数：9
相关论文
共 50 条
  • [1] Anti-CD20 monoclonal antibody therapy for non-Hodgkin's lymphoma (vol 10, pg 108, 1998)
    White, CA
    [J]. MINERVA BIOTECNOLOGICA, 1999, 11 (02) : 160 - 160
  • [2] Application of monoclonal anti-CD20 antibody rituximab in the treatment. of non-Hodgkin's lymphoma
    Mihaljevic, Biljana
    Jankovic, Snezana
    Jakovic, Ljubomir
    Jovanovic, Maja Perunicic
    Andelic, Bosko
    Milosevic, Violeta
    Sretenovic, Aleksandra
    Virijevic, Marjana
    Petrovic, Milan
    [J]. VOJNOSANITETSKI PREGLED, 2008, 65 (03) : 229 - 233
  • [3] Anti-CD20 monoclonal antibodies as novel treatments for non-Hodgkin's lymphoma
    White, CA
    Larocca, A
    Grillo-López, AJ
    [J]. PHARMACEUTICAL SCIENCE & TECHNOLOGY TODAY, 1999, 2 (03): : 95 - 101
  • [4] Rituximab anti-CD20 monoclonal antibody therapy in non-Hodgkin's lymphoma:: Safety and efficacy of re-treatment
    Davis, TA
    Grillo-López, AJ
    White, CA
    McLaughlin, P
    Czuczman, MS
    Link, BK
    Maloney, DG
    Weaver, RL
    Rosenberg, J
    Levy, R
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (17) : 3135 - 3143
  • [5] Extended Rituximab (anti-CD20 monoclonal antibody) therapy for relapsed or refractory low-grade or follicular non-Hodgkin's lymphoma
    Piro, LD
    White, CA
    Grillo-López, AJ
    Janakiraman, N
    Saven, A
    Beck, TM
    Varns, C
    Shuey, S
    Czuczman, M
    Lynch, JW
    Kolitz, JE
    Jain, V
    [J]. ANNALS OF ONCOLOGY, 1999, 10 (06) : 655 - 661
  • [6] Treatment of B cell low grade non-Hodgkin's lymphoma (NHL) with anti-CD20 monoclonal antibody Rituximab®
    Federico, M
    Clo, V
    Vinci, G
    Sacchi, S
    [J]. ANNALS OF ONCOLOGY, 1998, 9 : 32 - 32
  • [7] Radioimmunotherapy of relapsed non-Hodgkin's lymphoma with Zevalin, a 90Y-labeled anti-CD20 monoclonal antibody
    Wiseman, GA
    White, CA
    Witzig, TE
    Gordon, LI
    Emmanouilides, C
    Raubitschek, A
    Janakiraman, N
    Gutheil, J
    Schilder, RJ
    Spies, S
    Silverman, DHS
    Grillo-López, AJ
    [J]. CLINICAL CANCER RESEARCH, 1999, 5 (10) : 3281S - 3286S
  • [8] Administration guidelines for radioimmunotherapy of non-Hodgkin's lymphoma with 90Y-labeled anti-CD20 monoclonal antibody
    Wagner, HN
    Wiseman, GA
    Marcus, CS
    Nabi, HA
    Nagle, CE
    Fink-Bennett, DM
    Lamonica, DM
    Conti, PS
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2002, 43 (02) : 267 - 272
  • [9] Remission of inflammatory arthropathy in association with anti-CD20 therapy for non-Hodgkin's lymphoma
    Protheroe, A
    Edwards, JCW
    Simmons, A
    Maclennan, K
    Selby, P
    [J]. RHEUMATOLOGY, 1999, 38 (11) : 1150 - 1152
  • [10] Preclinical evaluation of 90Y-labeled anti-CD20 monoclonal antibody for treatment of non-Hodgkin's lymphoma
    Chinn, PC
    Leonard, JE
    Rosenberg, J
    Hanna, N
    Anderson, DR
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 1999, 15 (05) : 1017 - 1025
12345